B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells - PubMed (original) (raw)

. 1996 Jan 18;12(2):355-63.

Affiliations

PMID: 8570212

B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells

J Bies et al. Oncogene. 1996.

Abstract

B-Myb is a transcriptional regulator of gene expression and is highly homologous to c-Myb in its N-terminal DNA binding domain. However, unlike c-myb, whose expression is restricted largely to immature hematopoietic cells, B-myb mRNA has been found to be expressed in all proliferating mammalian cell lines and is clearly regulated in a cell cycle dependent manner. That c-Myb and B-Myb proteins perform different roles in proliferation and/or differentiation is suggested by the redundancy of their expression. It was previously shown that degenerated c-Myb expression can inhibit IL-6 induced terminal differentiation of the leukemia cell line M1. We found that, unlike the downregulation of c-Myb protein which is an early response of progenitor M1 cells to IL-6 treatment, the downregulation of B-Myb occurs late, just prior to terminal differentiation and growth arrest. It was, therefore, of interest to examine the role of the murine B-Myb protein in the proliferation and differentiation of the M1 cells and to compare these effects to those of c-Myb in the same system. Clones ectopically producing B-Myb, like those ectopically expressing c-Myb, proliferated in the presence of the differentiation-inducing agent and did not undergo the programmed cell death which normally follows terminal macrophage differentiation. In addition, the cell-cycle distribution of M1/B-Myb cells was comparable to untreated cells. Although M1/B-Myb and M1/c-Myb clones treated with IL-6 appeared quite immature, differentiation markers were demonstrated to be maintained at near normal levels (e.g. MyD88, Mac-2), or be partially reduced in expression (C3, Fc and Mac-1 receptors) suggesting that the cells had undergone commitment to maturation, but were unable to terminally differentiate.

PubMed Disclaimer

Cited by

The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.
Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El-Deiry WS, Tsichlis PN. Tong B, et al. Mol Cell Biol. 1998 May;18(5):2462-73. doi: 10.1128/MCB.18.5.2462. Mol Cell Biol. 1998. PMID: 9566867 Free PMC article.
B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.
Cicchillitti L, Jimenez SA, Sala A, Saitta B. Cicchillitti L, et al. Biochem J. 2004 Mar 1;378(Pt 2):609-16. doi: 10.1042/BJ20031110. Biochem J. 2004. PMID: 14613485 Free PMC article.
Integrative transcriptome analysis identifies MYBL2 as a poor prognosis marker for osteosarcoma and a pan-cancer marker of immune infiltration.
Qiu X, He H, Zeng H, Tong X, Zhang C, Liu Y, Liao Z, Liu Q. Qiu X, et al. Genes Dis. 2023 Jul 11;11(3):101004. doi: 10.1016/j.gendis.2023.04.035. eCollection 2024 May. Genes Dis. 2023. PMID: 38292182 Free PMC article.
Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.
Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L. Schmidt M, et al. Mol Cell Biol. 2000 Mar;20(6):1970-81. doi: 10.1128/MCB.20.6.1970-1981.2000. Mol Cell Biol. 2000. PMID: 10688644 Free PMC article.

B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells - PubMed (original) (raw)